PHARMACOLOGICAL STUDIES OF CAERULEIN II. THE POSSIBILITY OF MEDIATION THROUGH THE CENTRAL NERVOUS SYSTEM
スポンサーリンク
概要
- 論文の詳細を見る
With low doses of caerulein given intravenously or subcutaneously, vomiting could be induced. Although vomiting was not inhibited by chlorpromazine or atropine, a strong inhibition was evident when metoclopramide was administered subcutaneously at such doses as inhibit vomiting induced by oral administration of CuSO<SUB>4</SUB>. Even high doses of caerulein failed to induce vomiting in vagotomized and splanchnicotomized dogs. With intraventricular injection, no effects were observed on blood pressure, respiration or gastrointestinal motility, and vomiting was not induced. Therefore, a reflex mechanism appears to be involved in vomiting induced by caerulein. It is suggested that the actions of caerulein may not be mediated through the central nervous system.
- 社団法人 日本薬理学会の論文
著者
-
Marumo Hirofuto
Pharmaceuticals Research Laboratory Kyowa Hakko Kogyo Co. Ltd.
-
Kojima Tetsuo
Pharmaceuticals Research Laboratory Kyowa Hakko Kogyo Co. Ltd.
-
Shiozaki Shizuo
Pharmaceuticals Research Laboratory Kyowa Hakko Kogyo Co. Ltd.
-
NAKAMURA Nobuo
Pharmaceutical Research Laboratories, Fuji Plant, Kyowa Hakko Kogyo Co., Ltd.
-
KOYAMA Yoshihisa
Pharmaceutical Research Laboratories, Fuji Plant, Kyowa Hakko Kogyo Co., Ltd.
-
SHIOZAKI Shizuo
Pharmaceutical Research Laboratories, Fuji Plant, Kyowa Hakko Kogyo Co., Ltd.
-
MARUMO Hirofuto
Pharmaceutical Research Laboratories, Fuji Plant, Kyowa Hakko Kogyo Co., Ltd.
-
KOJIMA Tetsuo
Pharmaceutical Research Laboratories, Fuji Plant, Kyowa Hakko Kogyo Co., Ltd.
関連論文
- EFFECTS OF N-(4-METHYLBENZYLTHIOCARBONYL)-L-PHENYLALANINE (KF 1492), A NEW HYPOLIPIDEMIC DRUG, AND CLOFIBRATE ON LIPIDS METABOLISM
- EFFECTS OF N-(4-METHYLBENZYLTHIOCARBONYL)-L-PHENYL-ALANINE (KF 1492), A NEW PHENYLALANINE DERIVATIVE, ON LIPID SYNTHESIS IN VIVO INHIBITION OF HEPATIC CHOLESTEROL SYNTHESIS AND 3-HYDROXY-3-METHYLGLUTARYL-CO A REDUCTASE
- CHEMO-IMMUNOTHERAPY OF METHYLCHORANTHRENE-INDUCED FIBROSARCOMA BY CONCANAVALIN A-BOUND TUMOR VACCINE, LEVAMISOLE AND MITOMYCIN C
- EFFECT OF N-ACETYL-L-GLUTAMINE ALUMINUM COMPLEX (KW-110), AN ANTIULCER AGENT, ON THE NON-STEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED EXACERBATION OF GASTRIC ULCER IN RATS
- LIPID-LOWERING EFFECTS OF N-[4-METHYLBENZYLTHIOCARBONYL]-L-PHENYLALANINE (KF1492), A NEW PHENYLALANINE DERIVATIVE
- EFFECTS OF KW-5338 (DOMPERIDONE) ON GASTRIC MOTILITY
- ANTAGONISM OF KW-5338 (DOMPERIDONE) AGAINST EMESIS AND DEPRESSION OF INTESTINAL MOTILITY INDUCED BY L-DOPA
- EFFECTS OF PRAZOSIN, PHENTOLAMINE, AND YOHIMBINE ON THE PRESSOR RESPONSES INDUCED BY NORADRENALINE, PHENYLEPHRINE, AND BILATERAL CAROTID ARTERY OCCLUSION IN ANAESTHETIZED DOGS
- EFFECT OF SODIUM DIPROPYLACETATE ON CONFLICT BEHAVIOR IN RATS
- EFFECT OF L-5HTP ON TREMORINE- OR OXOTREMORINE- INDUCED TREMOR IN MICE AND RATS
- PHARMACOLOGICAL STUDIES OF CAERULEIN II. THE POSSIBILITY OF MEDIATION THROUGH THE CENTRAL NERVOUS SYSTEM
- INFLUENCE OF A NEW ANTIULCER AGENT, AMMONIUM 7-OXOBICYCLO (2, 2, 1) HEPT-5-ENE-3-CARBAMOYL-2-CARBOXYLATE (KF-392) ON GASTRIC LESIONS AND GASTRIC MUCOSAL BARRIER IN RATS